Form 8-K - Current report:
SEC Accession No. 0001558370-24-001116
Filing Date
2024-02-14
Accepted
2024-02-14 08:52:22
Documents
42
Period of Report
2024-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20240214x8k.htm   iXBRL 8-K 42942
2 EX-99.1 nrbo-20240214xex99d1.htm EX-99.1 44571
3 GRAPHIC nrbo-20240214x8k001.jpg GRAPHIC 12152
4 GRAPHIC nrbo-20240214xex99d1g001.jpg GRAPHIC 130749
5 GRAPHIC nrbo-20240214xex99d1g002.jpg GRAPHIC 214342
6 GRAPHIC nrbo-20240214xex99d1g003.jpg GRAPHIC 199333
7 GRAPHIC nrbo-20240214xex99d1g004.jpg GRAPHIC 125604
8 GRAPHIC nrbo-20240214xex99d1g005.jpg GRAPHIC 73332
9 GRAPHIC nrbo-20240214xex99d1g006.jpg GRAPHIC 147458
10 GRAPHIC nrbo-20240214xex99d1g007.jpg GRAPHIC 124348
11 GRAPHIC nrbo-20240214xex99d1g008.jpg GRAPHIC 147416
12 GRAPHIC nrbo-20240214xex99d1g009.jpg GRAPHIC 153915
13 GRAPHIC nrbo-20240214xex99d1g010.jpg GRAPHIC 151558
14 GRAPHIC nrbo-20240214xex99d1g011.jpg GRAPHIC 190679
15 GRAPHIC nrbo-20240214xex99d1g012.jpg GRAPHIC 190919
16 GRAPHIC nrbo-20240214xex99d1g013.jpg GRAPHIC 164736
17 GRAPHIC nrbo-20240214xex99d1g014.jpg GRAPHIC 138751
18 GRAPHIC nrbo-20240214xex99d1g015.jpg GRAPHIC 120942
19 GRAPHIC nrbo-20240214xex99d1g016.jpg GRAPHIC 183657
20 GRAPHIC nrbo-20240214xex99d1g017.jpg GRAPHIC 144851
21 GRAPHIC nrbo-20240214xex99d1g018.jpg GRAPHIC 210150
22 GRAPHIC nrbo-20240214xex99d1g019.jpg GRAPHIC 182625
23 GRAPHIC nrbo-20240214xex99d1g020.jpg GRAPHIC 130780
24 GRAPHIC nrbo-20240214xex99d1g021.jpg GRAPHIC 117430
25 GRAPHIC nrbo-20240214xex99d1g022.jpg GRAPHIC 114646
26 GRAPHIC nrbo-20240214xex99d1g023.jpg GRAPHIC 147671
27 GRAPHIC nrbo-20240214xex99d1g024.jpg GRAPHIC 112924
28 GRAPHIC nrbo-20240214xex99d1g025.jpg GRAPHIC 125802
29 GRAPHIC nrbo-20240214xex99d1g026.jpg GRAPHIC 135463
  Complete submission text file 0001558370-24-001116.txt   5598430

Data Files

Seq Description Document Type Size
30 EX-101.SCH nrbo-20240214.xsd EX-101.SCH 3147
31 EX-101.LAB nrbo-20240214_lab.xml EX-101.LAB 15266
32 EX-101.PRE nrbo-20240214_pre.xml EX-101.PRE 9672
43 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20240214x8k_htm.xml XML 4695
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 24632699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)